Retraction notice to "ß-elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome". LUNG 86/2 (2014) 144-150. Doi: 10.1016/j.lungcan.2014.08.015.;β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome

Lung Cancer

Volumn 86, Issue 2, 2014, Pages 144-150

  Li, Jianying ^a,b   Jun, Yu ^a   Liu, An ^a   Wang, Yili ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bcl 2; Bcl xl; Exosome; Lung cancer; P53; Elemene

Indexed keywords

BETA ELEMENE; MESSENGER RNA; PROTEIN P53; SMALL INTERFERING RNA; TRYPAN BLUE; ANTINEOPLASTIC AGENT; BETA-ELEMENE; SESQUITERPENE;

A549 CELL LINE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CELL GROWTH; CENTRIFUGATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; EXOSOME; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; MALE; MOUSE; MTT ASSAY; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; SESQUITERPENES; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908897430     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.03.003     Document Type: Erratum

References (35)

1. Zhao J., Li Q.Q., Zou B., Wang G., Li X., Kim J.E., Cuff C.F., Huang L., Reed E., Gardner K. In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma. Int J Oncol 2007, 31:241-252.
2. Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, Mariotto A, Miller B, Feuer E, Altekruse S. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute 2008: 1975-2005.
3. Li L, Xu L, Qu X, Zhao M, Yu P, Kang J, Liu Y, Hu X. Cbl-regulated Akt and ERK signals are involved in β-elemene-induced cell apoptosis in lung cancer cells. Molecular medicine reports 2011;4: 1243-1246.
4. Amano Y., Cho Y., Matsunawa M., Komiyama K., Makishima M. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells. J Steroid Biochem Mol Biol 2009, 114:144-151.
5. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., Keyomarsi K., Yarden Y., Seger R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001, 20:147.
6. Wang G., Li X., Huang F., Zhao J., Ding H., Cunningham C., Coad J., Flynn D., Reed E., Li Q. Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cellular Mol Life Sci CMLS 2005, 62:881-893.
7. Yao Y-Q., Ding X., Jia Y-C., Huang C-X., Wang Y-Z., Xu Y-H. Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 2008, 264:127-134.
8. Li X., Wang G., Zhao J., Ding H., Cunningham C., Chen F., Flynn D., Reed E., Li Q. Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci CMLS 2005, 62:894-904.
9. Tao L., Zhou L., Zheng L., Yao M. Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol 2006, 58:24-34.
10. Li Q.Q., Wang G., Zhang M., Cuff C.F., Huang L., Reed E. β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncology Rep 2009, 22:161-170.
11. Jiang H., Ma S., Feng J. In vitro study of radiosensitization by β-Elemene in A549 cell line from adenocarcinoma of lung. Chinese-German J Clin Oncol 2009, 8:12-15.
12. Li L.J., Zhong L.F., Jiang L.P., Geng C.Y., Zou L.J. β-Elemene radiosensitizes lung cancer A549 cells by enhancing DNA damage and inhibiting DNA repair. Phytother Res 2011, 25:1095-1097.
13. Simpson R.J., Jensen S.S., Lim J.W. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099.
14. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 1997, 8:2631-2645.
15. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and·-granules. Blood 1999, 94:3791-3799.
16. Taylor D.D., Doellgast G.J. Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography. Anal Biochem 1979, 98:53-59.
17. Taylor D.D., Homesley H.D., Doellgast G.J. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Cancer Res 1980, 40:4064-4069.
18. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21.
19. Olver C, Vidal M. Proteomic analysis of secreted exosomes. In: Subcellular Proteomics: Springer, 2007:99-131.
20. Choi D-S., Lee J-M., Park G.W., Lim H-W., Bang J.Y., Kim Y-K., Kwon K-H., Kwon H.J., Kim K.P., Gho Y.S. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007, 6:4646-4655.
21. Bard M.P., Hegmans J.P., Hemmes A., Luider T.M., Willemsen R., Severijnen L-A.A., van Meerbeeck J.P., Burgers S.A., Hoogsteden H.C., Lambrecht B.N. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 2004, 31:114-121.
22. Chaput N., Taïeb J., André F., Zitvogel L. The potential of exosomes in immunotherapy 2005.
23. Chen W., Wang J., Shao C., Liu S., Yu Y., Wang Q., Cao X. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Euro J Immunol 2006, 36:1598-1607.
24. Wang P., Henning S.M., Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PloS one 2010, 5:e10202.
25. Liu B., Peng X-C., Zheng X-L., Wang J., Qin Y-W. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines< i> in vitro and< i> in vivo. Lung Cancer 2009, 66:169-175.
26. Tu K., Zheng X., Zhou Z., Li C., Zhang J., Gao J., Yao Y., Liu Q. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 Pathway, Which Controls c-Myc and Cyclin E. PloS one 2013, 8:e68574.
27. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T) Method. Methods. 2001; 25 (4): 402-408. View this article via: PubMed CrossRef 2009.
28. Shen C., Buck A.K., Liu X., Winkler M., Reske S.N. Gene silencing by adenovirus-delivered siRNA. FEBS Lett 2003, 539:111-114.
29. Yu X., Harris S.L., Levine A.J. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006, 66:4795-4801.
30. Yang C., Robbins P.D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011, 2011.
31. Ettinger D.S., Akerley W., Bepler G., Blum M.G., Chang A., Cheney R.T., Chirieac L.R., D'Amico T.A., Demmy T.L., Ganti A.K.P. Non-small cell lung cancer. J Natl Comprehen Cancer Netw 2010, 8:740-801.
32. Valente L., Strasser A. Distinct target genes and effector processes appear to be critical for p53-activated responses to acute DNA damage versus p53-mediated tumour suppression. In:. BioDiscovery 2013.
33. Bacsó Z., Everson R.B., Eliason J.F. The DNA of annexin V-binding apoptotic cells is highly fragmented. Cancer Res 2000, 60:4623-4628.
34. Wolfers J., Lozier A., Raposo G., Regnault A., Théry C., Masurier C., Flament C., Pouzieux S., Faure F., Tursz T. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nature Med 2001, 7:297-303.
35. Koga K., Matsumoto K., Akiyoshi T., Kubo M., Yamanaka N., Tasaki A., Nakashima H., Nakamura M., Kuroki S., Tanaka M. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 2005, 25:3703-3707.